352 related articles for article (PubMed ID: 16352273)
21. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
[TBL] [Abstract][Full Text] [Related]
22. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
23. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
24. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
[TBL] [Abstract][Full Text] [Related]
25. [Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320 mgI/ml].
Amiel M; Revel D
Ann Radiol (Paris); 1989; 32(4 Pt 2):336-8. PubMed ID: 2688530
[TBL] [Abstract][Full Text] [Related]
26. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty.
Piessens JH; Stammen F; Vrolix MC; Glazier JJ; Benit E; De Geest H; Willems JL
Cathet Cardiovasc Diagn; 1993 Feb; 28(2):99-105. PubMed ID: 8448808
[TBL] [Abstract][Full Text] [Related]
27. Effects of monoionic and nonionic radiographic contrast media on cutaneous microcirculation in patients with peripheral arterial occlusive disease.
Franzeck UK; Schalch I; Seiler Y; Schneider E; Bollinger A
Microvasc Res; 1995 Jul; 50(1):18-24. PubMed ID: 7476576
[TBL] [Abstract][Full Text] [Related]
28. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
29. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
30. [Value of a new non-ionic contrast medium, iopromide 300 in renal arteriography using an arterial route. Comparative study with ioxaglate 320 mgI/ml].
Laval-Jeantet M; Martin-Bouyer Y
Ann Radiol (Paris); 1989; 32(4 Pt 2):344-6. PubMed ID: 2596812
[TBL] [Abstract][Full Text] [Related]
31. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
Lasser EC; Lyon SG; Berry CC
Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
[TBL] [Abstract][Full Text] [Related]
32. Renal effects of cardiac angiography with different low-osmolar contrast media.
Donadio C; Lucchesi A; Ardini M; Tramonti G; Chella P; Magagnini E; Bianchi C
Ren Fail; 2001; 23(3-4):385-96. PubMed ID: 11499554
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
[TBL] [Abstract][Full Text] [Related]
34. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
Shah B; Berger JS; Allen N; Guo Y; Sedlis SP; Xu J; Perez A; Attubato M; Slater J; Feit F
Catheter Cardiovasc Interv; 2016 Nov; 88(5):727-737. PubMed ID: 26773574
[TBL] [Abstract][Full Text] [Related]
35. [Tolerability of a new non-ionic contrast medium, iopromide in x-ray computed tomography. Comparison with ioxaglate 320 mgI/ml].
Fredy D; Heitz F; Mathieu D; Vasile N
Ann Radiol (Paris); 1989; 32(4 Pt 2):358-60. PubMed ID: 2688533
[TBL] [Abstract][Full Text] [Related]
36. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media.
Oi H; Yamazaki H; Matsushita M
Radiat Med; 1997; 15(1):23-7. PubMed ID: 9134581
[TBL] [Abstract][Full Text] [Related]
37. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
[TBL] [Abstract][Full Text] [Related]
38. Frequencies of reactions to iohexol versus ioxaglate.
Vacek JL; Gersema L; Woods M; Bower C; Beauchamp GD
Am J Cardiol; 1990 Nov; 66(17):1277-8. PubMed ID: 2239740
[No Abstract] [Full Text] [Related]
39. Haemostatic effects of low osmolar non-ionic and ionic contrast media: a double-blind comparative study.
Hoffmann JJ; Tielbeek AV; Krause W
Br J Radiol; 2000 Mar; 73(867):248-55. PubMed ID: 10817039
[TBL] [Abstract][Full Text] [Related]
40. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
